Search Rutgers Law Library N.J. Court Opinions

46 LEWIS GREEN et al. v. RIDGE TOOL CO. -- rank: 524

... 73 (App. Div.), certif. denied , 162 N.J. 199 (1999). N.J.S.A. 2A:58C-4 provides in relevant part: In any product liability action the ...

docket:	A1737-03
court:	NJ Superior Court Appellate Division
decided:	2006-03-23
status:	unpublished
citation:
Document Size:	120464

47 MICHAEL KORUBA v. AMERICAN HONDA MOTOR CO., INC. -- rank: 496

... Act), N.J.S.A. 2A:58C-1 to -7. N.J.S.A. 2A:58C-4, which essentially codifies the common law standard, Grier v. Cochran ...

docket:	a5953-05
court:	njappellate
decided:	2007-11-19
status:	published
citation:	396 N.J.Super. 517
Document Size:	63559

48 KELLY LEVEY v. YAMAHA MOTOR CORPORATION, U.S.A., -- rank: 469

... Act, N.J.S.A. 2A:58C-1 to -7. N.J.S.A. 2A:58C-4 provides that "[a]n adequate product warning or instruction is ... has discharged its duties as a "reasonably prudent [product seller]." N.J.S.A. 2A:58C-4. "Questions of reasonableness in determining the adequacy of warnings are ...

docket:	a6472-01
court:	njappellate
decided:	2003-06-24
status:	published
citation:	361 N.J. Super. 312
Document Size:	15901

49 MARY J. SCOTT v. ELI LILLY AND COMPANY -- rank: 462

... to counter the presumption that Zyprexa was properly labeled. See N.J.S.A. 2A:58C-4 (stating "[i]f the warning or instruction given in connection ...

docket:	a1701-14
court:	New Jersey Superior Court Appellate Division
decided:	2016-04-18
status:	Published
citation:
Document Size:	13337

50 SLAVO DOBROVIC, M.D. et al. v. STANLEY M. FRIEDMAN, M.D. -- rank: 441

... aff'd o.b. , 158 N.J. 329 (1999). And N.J.S.A. 2A:58C-4 provides that [i]n any product liability action the manufacturer ... concluded that plaintiff failed to rebut the statutory presumption under N.J.S.A. 2A:58C-4, that Lilly's FDA-approved warning was adequate. See Perez ...

docket:	a4206-03
court:	njappellate
decided:	2006-08-16
status:	unpublished
citation:	*CITE_PENDING*
Document Size:	60579

51 DAVID FACENDO V. S.M.S. CONCAST INC -- rank: 422

... because it: ... b. failed to contain adequate warnings or instructions... N.J.S.A. 2A:58C-4 defines an adequate warning as:         An adequate product warning or ...

docket:	a2466-94
court:	njappellate
decided:	1996-01-19
status:	published published
citation:	286 N.J.Super. 575
Document Size:	32383

52 WILBUR F. HENNING v. CASA DiBERTACCI, INC., ET AL. -- rank: 404

... by whom the product is intended to be used . . . .   [ N.J.S.A. 2A:58C-4.] Although a plaintiff's subjective knowledge of an obvious danger ...

docket:	a4129-05
court:	njappellate
decided:	2007-05-21
status:	unpublished
citation:	*CITE_PENDING*
Document Size:	42379

53 LANCE SAGER v. HOFFMAN-LA ROCHE, INC -- rank: 395

... the sufficiency of the FDA-approved warning, as reflected in N.J.S.A. 2A:58C-4, is a pertinent factor in evaluating the extent to which ...

docket:	a3427-09
court:	NJ Superior Court Appellate Division
decided:	2012-03-23
status:	unpublished
citation:
Document Size:	18637

54 LANCE SAGER v. HOFFMAN-LA ROCHE, INC -- rank: 395

... the sufficiency of the FDA-approved warning, as reflected in N.J.S.A. 2A:58C-4, is a pertinent factor in evaluating the extent to which ...

docket:	a3702-09
court:	NJ Superior Court Appellate Division
decided:	2012-03-23
status:	unpublished
citation:
Document Size:	18637

55 LANCE SAGER v. HOFFMAN-LA ROCHE, INC -- rank: 395

... the sufficiency of the FDA-approved warning, as reflected in N.J.S.A. 2A:58C-4, is a pertinent factor in evaluating the extent to which ...

docket:	a3428-09
court:	NJ Superior Court Appellate Division
decided:	2012-03-23
status:	unpublished
citation:
Document Size:	18637